Translational Development Acquisition Corp. Ordinary Shares Financial Flexibility Index
Translational Development Acquisition Corp. Ordinary Shares financial flexibility index. Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Financial Flexibility Index of -0.04x as of June 2026. Free cash flow of $-338.75K (operating CF $-338.75K minus capex $3.00) represents 0% of total liabilities ($7.79 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Translational Development Acquisition Corp. Ordinary Shares (2022–2025)
Financial flexibility index of Translational Development Acquisition Corp. Ordinary Shares from 2022 to 2025. Historical Financial Flexibility Index trend for Translational Development Acquisition Corp. Ordinary Shares across 4 annual periods. Check TDAC cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Translational Development Acquisition Corp. Ordinary Shares Financial Flexibility Index by Year (2022–2025)
Translational Development Acquisition Corp. Ordinary Shares financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Translational Development Acquisition Corp. Ordinary Shares. For the full cash flow conversion analysis, see Translational Development Acquisition Co (TDAC) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.09x | $-608.38K | $-608.39K | $6.58 Million | ▲ +32.2% |
| 2024 | -0.14x | $-851.44K | $-851.45K | $6.25 Million | ▼ -33948.2% |
| 2023 | 0.00x | $-204.00 | $-204.00 | $509.68K | ▲ +99.8% |
| 2022 | -0.21x | $-97.16K | $-97.16K | $459.34K | — |